45+ Medicare companies and brands analyzed by our team of experts. 30+ years of combined experience covering Medicare and personal finance. Governed by NerdWallet's strict guidelines for editorial ...
Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...
Humana is one of the many Medicare-approved private insurance companies that offer Medicare Advantage (Part C) plans. These plans are an alternative to Original Medicare (Part A and Part B) plans.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025. Humana’s ...
Humana is modifying its Medicare Advantage products for 2025 amid industrywide struggles with higher costs under the program, the company announced along with its second-quarter results Wednesday.
The healthcare sector, led by insurance stocks, has faced chronic underperformance since 2020 as premiums fail to keep up with costs. Humana has faced significant pressures, losing over 30% of its ...
(Reuters) -A U.S. judge on Tuesday rejected Humana's bid to challenge the Centers for Medicare & Medicaid Services' 2025 ratings for its Medicare Advantage plans, which could cost the health insurance ...
Humana, one of the two biggest players in the Medicare Advantage market, is being hit with high benefit expenses due to high utilization among its members, according to a June 16 filing with the ...
Zacks Investment Research on MSN
Humana partners with Atlas to enhance cancer care for seniors
Humana Inc. HUM recently unveiled a tie-up with Atlas Oncology Partners in a bid to provide enhanced cancer care, ...
Thousands of patients insured through Humana's Medicare Advantage plans are no longer "in network" at Aultman hospitals. Adam Luntz, senior vice president of finance at Aultman, said the contract ...
MarketBeat on MSN
Humana Gains Despite Medicare Advantage Losses-What's the Catch?
Health insurance giant Humana Inc. (NYSE: HUM) stock initially rose in reaction to its fourth quarter of 2024 earnings report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results